LU75217A1 - - Google Patents

Info

Publication number
LU75217A1
LU75217A1 LU75217A LU75217A LU75217A1 LU 75217 A1 LU75217 A1 LU 75217A1 LU 75217 A LU75217 A LU 75217A LU 75217 A LU75217 A LU 75217A LU 75217 A1 LU75217 A1 LU 75217A1
Authority
LU
Luxembourg
Application number
LU75217A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19752528078 external-priority patent/DE2528078A1/de
Priority claimed from DE19752548663 external-priority patent/DE2548663A1/de
Application filed filed Critical
Publication of LU75217A1 publication Critical patent/LU75217A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU75217A 1975-06-24 1976-06-22 LU75217A1 (mo)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19752528078 DE2528078A1 (de) 1975-06-24 1975-06-24 Beta-lactam-antibiotika, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE19752548663 DE2548663A1 (de) 1975-10-30 1975-10-30 Beta-lactam-verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
LU75217A1 true LU75217A1 (mo) 1977-03-15

Family

ID=25769060

Family Applications (1)

Application Number Title Priority Date Filing Date
LU75217A LU75217A1 (mo) 1975-06-24 1976-06-22

Country Status (15)

Country Link
JP (1) JPS525789A (mo)
AU (1) AU498022B2 (mo)
CH (1) CH624958A5 (mo)
DD (1) DD126740A5 (mo)
DK (1) DK281276A (mo)
ES (1) ES449140A1 (mo)
FI (1) FI761807A7 (mo)
FR (1) FR2316940A1 (mo)
GB (1) GB1538284A (mo)
GR (1) GR60558B (mo)
IE (2) IE44290B1 (mo)
IL (1) IL49846A (mo)
LU (1) LU75217A1 (mo)
NL (1) NL7606789A (mo)
SE (1) SE7607218L (mo)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5985147U (ja) * 1982-11-30 1984-06-08 ワイケイケイ株式会社 ブラインド清掃装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2407715C2 (de) * 1974-02-18 1982-12-02 Bayer Ag, 5090 Leverkusen Cephalosporine, Verfahren zu ihrer Herstellung sowie Arzneimittel
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same

Also Published As

Publication number Publication date
IL49846A0 (en) 1976-08-31
AU1521976A (en) 1978-01-05
CH624958A5 (en) 1981-08-31
SE7607218L (sv) 1976-12-25
GR60558B (en) 1978-06-22
DK281276A (da) 1976-12-25
IE44289L (en) 1976-12-24
FR2316940B1 (mo) 1978-12-15
IL49846A (en) 1979-07-25
IE44290B1 (en) 1981-10-07
JPS525789A (en) 1977-01-17
ES449140A1 (es) 1977-07-16
AU498022B2 (en) 1979-02-01
FI761807A7 (mo) 1976-12-25
IE44289B1 (en) 1981-10-07
FR2316940A1 (fr) 1977-02-04
NL7606789A (nl) 1976-12-28
DD126740A5 (mo) 1977-08-10
GB1538284A (en) 1979-01-17

Similar Documents

Publication Publication Date Title
JPS5223916B2 (mo)
JPS5626201B2 (mo)
JPS5646432B2 (mo)
FR2316940B1 (mo)
JPS5243212U (mo)
JPS51133899U (mo)
JPS5275535U (mo)
JPS5230307U (mo)
JPS51103509U (mo)
JPS51145318U (mo)
JPS5211766U (mo)
CH596119A5 (mo)
BG21530A1 (mo)
CH600675A5 (mo)
CH576092A5 (mo)
BG21435A1 (mo)
CH593593A5 (mo)
CH600713A5 (mo)
CH603493A5 (mo)
BG22893A1 (mo)
CH599497A5 (mo)
CH597482A5 (mo)
BG21749A1 (mo)
CH600083A5 (mo)
CH597750A5 (mo)